Stock options granted generally vest over a period of five years and have contractual terms to exercise of 10 years. A summary of stock option activity is as follows (in thousands, except option prices and years):


	Number of Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value (1)
Options Outstanding at May 27, 2023		856		$	9.07
Granted		205			15.51
Exercised		(75	)		7.91
Forfeited		(18	)		9.32
Cancelled		(10	)		11.70
Options Outstanding at June 1, 2024		958		$	10.51
Granted		184			11.89
Exercised		(47	)		6.76
Forfeited		(6	)		11.80
Cancelled		(17	)		10.11
Options Outstanding at May 31, 2025		1,072		$	10.91
Granted		195			9.73
Exercised		(142	)		7.00
Options Outstanding at May 30, 2026		1,125		$	11.20		6.2	$	6,504
Options Vested at May 30, 2026		583		$	10.41		4.6	$	3,834

(1)

Includes only those options that were in-the-money as of May 30, 2026. Stock options for which the exercise price exceeded the market price have been omitted. Fluctuations in the intrinsic value of both outstanding and exercisable options may result from changes in underlying stock price and timing and volume of option grants, exercises and forfeitures.

There were 141,763 stock options exercised during fiscal 2026, with cash received of $1.0 million. The total intrinsic value of options exercised was $0.9 million during fiscal 2026, $0.3 million during fiscal 2025, and $0.3 million during fiscal 2024. The weighted average fair value of stock option grants was $3.94 during fiscal 2026, $4.95 during fiscal 2025, and $6.33 during fiscal 2024. As of May 30, 2026, total unrecognized compensation costs related to unvested stock options and restricted stock awards was $2.6 million, which is expected to be recognized over the remaining weighted average period of approximately two to four years. The total grant date fair value of stock options vested during fiscal 2026 was $0.6 million.

The fair value of stock options is estimated using the Black-Scholes option-pricing model with the following weighted average assumptions:


	Fiscal Year Ended
	May 30, 2026			May 31, 2025			June 1, 2024
Expected volatility		49.23	%		48.07	%		44.80	%
Risk-free interest rate		3.91	%		4.17	%		4.02	%
Expected life (years)		5.70			5.67			5.61
Annual cash dividend	$	0.24		$	0.24		$	0.24

The expected volatility assumptions are based on historical experience commensurate with the expected term. The risk-free interest rate is based on the yield of a treasury note with a remaining term equal to the expected life of the stock option. The expected term of stock options is estimated from the vesting period of the award and represents the weighted average period that our stock options are expected to be outstanding.

Compensation effects arising from issuing stock awards have been charged against income and recorded as additional paid-in-capital in the Consolidated Statements of Stockholders’ Equity during fiscal 2026, fiscal 2025 and fiscal 2024.

The Amended and Restated 2011 Long-Term Incentive Compensation Plan (the "Plan") authorized the issuance of up to 3,500,000 shares as incentive stock options, non-qualified stock options or stock awards. On October 7, 2025, the Company held an annual meeting of its stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment and restatement of the Plan to increase the number of shares authorized for issuance thereunder by 2,000,000 shares, for a total of 5,500,000 shares. Under this plan, 2,085,914 shares are reserved for future issuance. The Plan authorizes the granting of stock options at the fair market value at the date of grant. Generally, these options become exercisable over five years and expire up to 10 years from the date of grant. Restricted stock awards vest on the anniversary of the grant date in three equal installments.